-
September 11, 2025 Cystic Fibrosis recognised as a Communicable DiseaseCystic fibrosis has been officially included in the list of communicable diseases. An important moment for the patient...
-
August 1, 2025 The President of our Association at the EURORDIS Membership Meeting 2025The Panhellenic Cystic Fibrosis Association participated in the Annual EURORDIS (EMM 2025) Members' Conference in Riga, focusing on...
-
July 31, 2025 Our Association participated in the 48th European Congress of Cystic Fibrosis – ECFS 2025The Panhellenic Cystic Fibrosis Association actively participated in the 48th European Congress ECFS 2025 and the annual General...
-
July 24, 2025 The voice of the patients brings results – Pneumologist appointment & positive developments at the K.I. Sismanoglio CentreThe voice of the patients makes a difference. Following targeted interventions by the Panhellenic Cystic Fibrosis Association, the...
-
July 2, 2025 European approval of new innovative treatment Alyftrek for Cystic FibrosisThe new Alyftrek® treatment for Cystic Fibrosis has been approved by the European Medicines Agency. Which patients are...
-
June 23, 2025 Cystic Fibrosis Webinar at AB Vassilopoulos: “Unlimited Breath” – Life with an invisible diseaseThe webinar “Unlimited Breath” at AB Vassilopoulos highlighted the challenges of living with Cystic Fibrosis and lung transplantation,...
-
October 30, 2023 HIT-CF program for rare mutations – August 2023 UpdateResubmission of the "Choices" clinical trial to CTIS, after its initial rejection, is being prepared by the European...
-
October 25, 2023 Bronze Healthcare Award 2023 for the Hellenic Cystic Fibrosis Association!The Hellenic Cystic Fibrosis Association was awarded with the Bronze Healthcare Award 2023 for its psychosocial support programme,...
-
October 11, 2023 Concert 40 years HCFA “Breath Unlimited- Be a life donor” with support of President of Hellenic Republic & Minister of HealthThe Hellenic Cystic Fibrosis Association held an awareness concert on the occasion of the 40th anniversary of its...
-
September 25, 2023 CHMP positive opinion for Kaftrio/Kalydeco in CF children 2-5 y.o.European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for the...
- 01
- 02